| AFC-HD AMS Life Science Co. Ltd. (2927.TO) | ||
| Japan | ||
| Year Ended August 31 | ||
| GROUP | 2024 | 2023 |
| Revenue | Y30.19 bln | Y25.58 bln |
| Operating Profit | Y1.92 bln | Y1.64 bln |
| Pretax Profit | Y1.92 bln | Y1.65 bln |
| Net Profit | Y1.25 bln | Y1.10 bln |
| Per share | ||
| Earnings | Y89.20 | Y78.51 |
| Diluted Earnings | Y89.11 | Y78.46 |
| Results are based on Japanese accounting standards. |
This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.
(MORE TO FOLLOW) Dow Jones Newswires
November 08, 2024 01:31 ET (06:31 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.